Alle afleveringen
364 afleveringen, van nieuw naar oud
-
Mapping the landscape of clinical trial regulation
25 augustus 2023 · 29 min
In today’s podcast, Medable Chief Science Officer Dr. Pamela Tenaerts joins host Jonah Comstock to discuss the current state of regulations in DCTs and what’s currently lacking.
-
Preparing for the tsunami of healthcare data approaching
15 augustus 2023 · 20 min
In a new pharmaphorum podcast, web editor Nicole Raleigh spoke with Michael Ibara, chief data officer at Elligo Health Research, discussing AI in clinical research and its overall impact on healthcare.
-
Alzheimer’s drugs: An overview and update
10 augustus 2023 · 34 min
In the latest episode of the podcast, pharmaphorum Editor in Chief Jonah Comstock welcomes Dr. Alvaro Pascual-Leone, a neurology professor at Harvard Medical School, to the podcast to discuss how two new potentially groundbreaking Alzheimer's drugs work, describes the differences and similarities between them, and details both their exciting potential and their potential limitations. He also talks about the need for a holistic approach to Alzhemier’s treatment and the importance of lifestyle changes and early detection in fully addressing this devastating disease. Lees meer
-
Suffering beyond physical effects: inequalities and taboos in prostate cancer
1 augustus 2023 · 12 min
In this episode of the pharmaphorum podcast, web editor Nicole Raleigh speaks with André Deschamps, formerly president of Europa Uomo, the voice of men with prostate cancer in Europe. Deschamps is now involved in the Let’s Talk Prostate Cancer (LTPC) Expert Group, as well as the Belgian society, Wij Ook (part of Europa Uomo). Lees meer
-
Collaborative perseverance to bring change to medicine access
28 juli 2023 · 26 min
Recently, pharmaphorum web editor Nicole Raleigh spoke with Herbert Altmann, head of commercialisation and access solutions Europe at PharmaLex, and Casper Paardekooper, partner at Vintura. AmerisourceBergen completed the acquisition of PharmaLex (and Vintura, which was owned by PharmaLex). Lees meer
-
Botanicals in pharma: Potential and pitfalls
27 juli 2023 · 29 min
In today’s podcast, Saad Harti, founder and CEO of Legacy Healthcare, joins Editor in Chief Jonah Comstock to discuss this exciting old, yet new category.
-
Clinical trial diversity: An update
13 juli 2023 · 32 min
Editor in Chief Jonah Comstock welcomes back returning guest Dr. Jennifer Jones-McMeans, divisional vice president for global affairs for Abbot’s vascular business. Jennifer was on the podcast just over a year ago to talk about the importance of clinical trial diversity, and she’s back with an update on that important topic, as well as some news from Abbott in that area. Lees meer
-
Changing personnel dynamics in the pharma world
6 juli 2023 · 28 min
In this episode of the pharmaphorum podcast, brought to you by Advanced Clinical, Advanced Clinical’s SVP Strategic Resourcing Steve Mattas and VP of Global Talent and Client Delivery James Nyssen speak with host Jonah Comstock about findings from a recent report by their company on the current personnel dynamics in pharma. Lees meer
-
Retaining the human quality of healthcare in DTx
5 juli 2023 · 20 min
As DTx Europe came to a close at the British Medical Association in London, pharmaphorum web editor Nicole Raleigh spoke with Digital Medicine Society (DiMe) program lead, Alex Despotovic, discussing adoption of digital therapeutics and digital technologies in general in clinical practice, and the impact of the event itself overall. Lees meer
-
Focusing on predictability and execution in digital trials
28 juni 2023 · 35 min
Recently attending the Veeva R&D and Quality Summit in Madrid, pharmaphorum web editor Nicole Raleigh sat down with Veeva’s president of Europe, Chris Moore. The event seen as a chance to bring the whole industry together, Moore explained how there is an excitement in the industry currently, with more drugs being developed, more conditions being treated – including those not before addressed – and that Veeva is endeavouring to do what it can to help raise the industry capabilities. So it is that the event has become a test bed to see whether the company is on the right track. Lees meer
-
Genetic testing update with 23andMe’s Noura Abul-Husn
16 juni 2023 · 30 min
In the latest instalment of the pharmaphorum podcast, Editor in Chief Jonah Comstock is joined by Dr Noura Abul-Husn, VP of genomic health at 23andMe.
-
Headlines and hot topics from ASCO and BIO
9 juni 2023 · 44 min
This week, pharmaphorum editor-in-chief Jonah Comstock headed to not one but two back-to-back events in the US. Starting with the American Society of Clinical Oncology’s (ASCO) annual conference in Chicago, before hitting the floor at the BIO International Convention in Boston, there was plenty of innovation, news, and expert knowledge on display. Lees meer
Fresh from the floor of BIO International, Jonah sat down with pharmaphorum Deep Dive editor Eloise McLennan to reflect on the biggest topics and trends from each event – and the impact these developments may have on pharma over the coming months.
-
The precision element at the heart of digital transformation
30 mei 2023 · 11 min
On the final day of Reuters Pharma Barcelona back in March, web editor Nicole Raleigh sat down with Graphite Digital’s CEO, Rob Verheul. The company – which has been working in the industry for 13 years now – has most recently been focusing on HCP engagement at a global scale, through use of digital channels. Lees meer
-
AI in drug development: A reality check
25 mei 2023 · 27 min
In this episode of the pharmaphorum podcast, Editor in Chief Jonah Comstock catches up with Adityo Prakash, CEO of Verseon, to shed some light on what the potential of AI in drug discovery really is.
-
Epiphany moments in an industry starved of insights
22 mei 2023 · 12 min
Back in March at Reuters Pharma Barcelona, pharmaphorum’s web editor Nicole Raleigh met up with CEO of Within3, Lance Hill. Having met up in Nice in 2022, it was interesting to ‘get up to speed’ a year later. Lees meer
Discussing how the industry is ‘starved’ of insights – with so much data from so many sources, fragmented, regional, and disconnected, that decisions cannot be reached in the timeframes necessary – Hill defines insights as the epiphany moments; what permit the right actions and determine the trajectory of a therapy.
-
A closer look at gene therapy with PTC Therapeutics
18 mei 2023 · 20 min
In the latest instalment of the pharmaphorum podcast, Editor in Chief Jonah Comstock connects with Kylie O’Keefe to talk about gene therapy in rare diseases. Lees meer
They discuss what different gene therapies have in common and how some particular therapies work. They also talk about what gene therapy means for the industry and for patients, in particularly the paradigm shift of disease-modifying therapies.
-
WWD: Ready, Set, Food! CEO, Daniel Zakowski
11 mei 2023 · 13 min
On 21st June, London’s prestigious Royal Society of Medicine will play host to some of the sharpest minds in healthcare as they come together for the inaugural World Without Disease conference, developed by pharmaphorum and the CWWDA. Lees meer
One of these minds is Daniel Zakowski, CEO of Ready, Set, Food!, who will be taking the stage to discuss why preventing childhood food allergies is an important step in the journey towards the vision of a disease-free world.
-
The Hidden Burden of Stigmatised Health Conditions
2 mei 2023 · 53 min
Having any chronic health condition is complicated, difficult, and scary. But add in a cultural or social stigma and you create whole new levels of challenge. Lees meer
In today’s pharmaphorum podcast, brought to you by Cerner Enviza, an Oracle company, editor in chief Jonah Comstock welcomes Nate Way, senior evidence generation lead at Cerner Enviza and James Geary MBA, MHA, a data analyst who also lives with Cerebral Palsy and anxiety and depression.
-
Creating healthier futures - Reuters Pharma Barcelona 2023
2 mei 2023 · 18 min
In this latest mini pharmaphorum podcast, web editor Nicole Raleigh spoke with Tommy Bramley, SVP of global consulting at Amerisource Bergen, whilst attending Reuters Pharma Barcelona.
-
Inside the new world of healthcare data
20 april 2023 · 32 min
On today’s pharmaphorum podcast, Evidation’s Executive Chair of the Board Deborah Kilpatrick joins host Jonah Comstock to talk about healthcare data collection in 2023 and how it intersects with stakeholders across the ecosystem, from tech and pharma companies to research participants. Lees meer
-
Restoring sensitivity to targeted therapies
14 april 2023 · 20 min
In this new episode of the mini pharmaphorum podcast, web editor Nicole Raleigh spoke with Simon Powell, CEO of Ribonexus, a new company put together to develop and ultimately commercialise long-standing research programmes from Gustav Roussy, Institut Curie, the University of Strasbourg, and Pierre Fabre, to develop drugs that overcome tumour resistance to existing drug treatments. Lees meer
-
Insulin costs & pharma manufacturing
13 april 2023 · 42 min
In today’s pharmaphorum podcast, brought to you by Lannett Corporation, editor in chief Jonah Comstock first chats with Timothy Crew, CEO of Lannett. Crew talks about the contract development manufacturing organisation (CDMO) business and why local manufacturing is important in the United States. Lees meer
Then, in part 2, Jonah talks to Tom Lewis, Lannett’s VP of Global Supply Chain and CDMO Management. They discuss Lannett’s CDMO business more broadly, how it works, and why it’s an important offering in today’s pharma landscape.
-
What the low impact of Humira biosimilars teaches us about drug prices
6 april 2023 · 40 min
Almost everyone seems to agree that drug prices are too high. But that agreement stops when it comes to the question of why they’re so high, and to the question of how to bring them down. Lees meer
Goodroot CEO Mike Waterbury and Nuwae Health CEO Ralph Pisano discuss how the community of Goodroot companies, including Nuwae, are attacking that issue from different angles.
-
Transforming healthcare: Nils Bottler and Paul Tunnah
30 maart 2023 · 20 min
Angelini Ventures is a recently launched investment fund seeking companies that are transformational in healthcare. Founder of pharmaphorum and Healthware Group's chief content officer, Paul Tunnah, talks with Nils Bottler, who recently joined Angelini Ventures as Principal, about his career and where Angelini Ventures aims to have an impact. Lees meer
-
Challenges and opportunities with plasma-derived therapies
23 maart 2023 · 28 min
For the newest pharmaphorum podcast, editor in chief Jonah Comstock welcomes Dr. Kristina Allikmets, SVP and head of R&D at Takeda’s plasma-derived therapies business unit.
-
CinCor Pharma: A small pharma’s journey to acquisition
10 maart 2023 · 28 min
In this episode of the pharmaphorum podcast, host Jonah Comstock welcomes Marc de Garidel, CEO of CinCor Pharma, which was just recently sold to AstraZeneca for more than $1 billion USD. Marc tells Jonah all about CinCor and its unique approach to hypertension, how the AstraZeneca deal came about, and what happens next. Lees meer
-
AI trends in 2023
2 maart 2023 · 41 min
No matter what industry you’re in, artificial intelligence is a major topic around the water cooler. But while AI in popular culture may be at a peak of hype, AI in pharma is strending toward a moment of maturity, reliability, and scalability. Lees meer
In today’s pharmaphorum podcast, brought to you by Syneos Health, Leigh Householder, EVP and MD technology and data solutions at Syneos Health and Noolie Gregory, VP decentralised clinical trial operations at Syneos Health, join host Jonah Comstock to talk about the Syneos Health 2023 Health Trends Report, particularly the opening section on AI: Finally Fit for Purpose.
-
Accelerating digital healthcare, with VITA
1 maart 2023 · 20 min
At the beginning of February, pharmaphorum web editor Nicole Raleigh travelled to Rome to cover the inaugural VITA Accelerator demo day. After the event, VITA’s senior programme manager Anastasiya Markvarde and managing director Paolo Borella took time to discuss the ethos behind the accelerator and the future of digital health start-ups in Italy and beyond. Lees meer
-
Investing in healthcare’s future, with Paul Tunnah and Elia Stupka
17 februari 2023 · 36 min
Angelini Ventures is a recently launched investment fund seeking companies that are transformational in healthcare. pharmaphorum founder and Healthware Chief Content Officer Paul Tunnah, talks with co-Managing Director Elia Stupka about the new €300 million fund, how it started, how it’s going, and what health innovation looks like from the investor’s perspective. Lees meer
This podcast was produced in partnership with Angelini Ventures and was originally published on Matthew Holt’s Healthcare Blog Podcast.
-
Solving problems in pathology data, with Nathan Buchbinder
9 februari 2023 · 27 min
This time around on the pharmaphorum podcast, Editor in Chief Jonah Comstock chats with Nathan Buchbinder, cofounder and chief product officer at Proscia about pathology data, why it has taken so long to digitise it, and what the possibilities are when this data is freed from its historical siloes. Lees meer
-
How Moderna kept diversity in mind amid vaccine development
26 januari 2023 · 30 min
In the newest episode of the pharmaphorum podcast, Editor in Chief Jonah Comstock speaks with Jameka Hill, senior director of clinical trial health equity at Moderna.
-
Key themes from JP Morgan, with Paul Tunnah
12 januari 2023 · 21 min
pharmaphorum Editor-in-Chief Jonah Comstock and pharmaphorum Founder Paul Tunnah headed to San Francisco this week for the JP Morgan conference, the annual elbow-rubbing opportunity for biotech bigwigs. This is the first time the show has been back in person since COVID, and, despite some less than ideal weather, attendees were excited to resume in person collaboration. Lees meer
-
Cancer control in a time of crisis
5 januari 2023 · 20 min
During The Economist’s 8th Annual World Cancer Series congress in Brussels last month, web editor Nicole Raleigh sat down to discuss the event and its themes with Greg Rossi, senior vice president, head of oncology Europe and Canada at AstraZeneca .
-
The scattered seeds of the beginnings of change
30 december 2022 · 7 min
Speaking with Rob Verheul, CEO of Graphite Digital, at Anthropy 2022 at the Eden Project, pharmaphorum web editor Nicole Raleigh enjoyed a minute discussing the event and what specifically had attracted Verheul to attend.
-
A few of the 2022’s biggest pharma trends
29 december 2022 · 46 min
As we close out the year, the pharmaphorum editorial team sits down together for a roundtable discussion of some of the biggest trends they’ve tracked this year in the world of pharma.
-
Exploring the importance we play in our own health maintenance
23 december 2022 · 13 min
While at Anthropy 2022, pharmaphorum’s web editor Nicole Raleigh briefly spoke with Karyn Johnston, chief executive of East Cheshire Hospice, who had taken part in the Adelphi Group’s panel, ‘Later life care and dementia’.
-
Focusing on the evolution of biotechnology and R&D
22 december 2022 · 13 min
Following an invite to fly into Parma, Italy to witness first-hand the press launch of the considerable structure that is the Chiesi Group’s new €85 million Biotech Centre of Excellence, pharmaphorum web editor Nicole Raleigh spoke with Chiesi’s head of global manufacturing, Antonio Magnelli. Lees meer
-
Innovations in Real-World Evidence (live from PharmStars)
15 december 2022 · 19 min
On today’s pharmaphorum podcast, host Jonah Comstock takes us to the PharmStars presentation last month at the Boston Seaport, with interviews conducted at the event. The topic: Innovations in Real-World Evidence.
-
Continuing to keep COVID-19 at bay
8 december 2022 · 25 min
Flying into London recently for the Jefferies Conference, Novavax’s EVP, chief commercial officer, and chief business officer John Trizzino, together with the company’s chief medical officer Filip Dubovsky, took time out of very packed schedules indeed to speak with pharmaphorum Web editor Nicole Raleigh in a small (though not always necessarily quiet) corner of the One Aldwych Hotel on the Strand. Lees meer
-
Can VR technology make physical therapy fun
1 december 2022 · 22 min
In the newest episode of the pharmaphorum podcast, editor in chief Jonah Comstock chats with Gita Barry, EVP and GM of Immersive Healthcare at Penumbra, a therapeutic VR company.
-
Exploring a united vision for British pharma at Anthropy
28 november 2022 · 20 min
Anthropy 2022 brought climate change to industry in Cornwall in (a very wet and windy) early November, settling cosily into the truly eco-minded environs of the Eden Project and firing up fervent and necessary conversations on sustainability, accessibility, and action plans. Lees meer
Amidst all this, Adelphi Group’s CEO Stuart Cooper found a moment to sit with pharmaphorum web editor Nicole Raleigh and discuss just how exciting it was to bring to vibrant and discursive life the ethos of Anthropy – a united vision for British business, including pharma, and the future of this nation overall.
-
What we heard and saw at HLTH22, with Matthew Holt
24 november 2022 · 49 min
pharmaphorum Editor-in-Chief Jonah Comstock traveled to Las Vegas last week with thousands of other healthcare stakeholders for the HLTH 2022 conference. Lees meer
In this post-show edition of the pharmaphorum podcast, Jonah welcomes Matthew Holt, editor of The Healthcare Blog and former digital health event organiser, to discuss the show itself and the content therein.
-
Disrupting the standard of healthcare for Bangladesh
18 november 2022 · 10 min
In this mini episode of the pharmaphorum podcast, web editor Nicole Raleigh spoke with Sylvana Sinha, founder, chair, and CEO of Praava Health, Bangladesh’s fastest growing healthcare brand.
-
How immersive audio can be a therapeutic tool
17 november 2022 · 30 min
In this episode of the pharmaphorum podcast, Editor in Chief Jonah Comstock chats with Howard Rose, head of health and wellness at Spatial about immersive audio: what it is, how it works, and how it can help in healthcare.
-
A new hope in cachexia and an outsider’s view on pharma
10 november 2022 · 21 min
In the latest installment of the pharmaphorum podcast, Editor in Chief Jonah Comstock sits down with Russell Potterfield, CEO at Endevica Pharma. Lees meer
A biotech CEO who comes from the business and investment worlds, Russell now runs Endevica, which is working on a novel therapy for cachexia, a wasting syndrome that accompanies many cancers.
-
Why is digital health so challenging for big tech?
3 november 2022 · 27 min
In this episode of the pharmaphorum podcast, host Jonah Comstock taps XIL Health’s Susan Lang to better understand why big tech’s ventures into healthcare seem to stumble more often than not.
-
Live from Frontiers Health 2022 - the pharmaphorum podcast
27 oktober 2022 · 29 min
In this special, live edition of the pharmaphorum podcast, recorded at the conclusion of Frontiers Health 2022, pharmaphorum Editor in Chief Jonah Comstock and pharmaphorum Web Editor Nicole Raleigh are joined by author, consultant, and podcast host Tony Estrella and Healthware Labs Managing Director Kristin Milburn to discuss their key takeaways from the show last week in Milan. Lees meer
-
Live from Reuters Pharma 2022 - the pharmaphorum podcast
20 oktober 2022 · 37 min
In mid-October, our Web Editor Nicole Raleigh and Deep Dive Editor Eloise McLellan traveled to Nice for the Reuters Pharma event. Lees meer
This special episode includes a conversation recorded on-site with Nicole, Eloise, Virtual Science AI CEO Thomas Hughes, and VSAI VP of global patient affairs Geraldine Reilly.
And stay tuned for the second half of the episode, where Nicole speaks with Sabine Hutchison, CEO and co-founder of Seuss+, about the Dutch consulting firm’s work with smaller life science companies.
-
Building agile partner relationships at a vaccine-focused biotech
13 oktober 2022 · 47 min
In this episode of the pharmaphorum, Dr Paul Tunnah chats with Jeff Baxter, CEO of VBI Vaccines and Lee Taurman, executive vice president full service commercial at Syneos Health.
-
Understanding the tumour micro-environment – the pharmaphorum podcast
6 oktober 2022 · 20 min
Dr Marie-Louise Fjällskog, chief medical officer at Faron Pharmaceuticals, joins host Jonah Comstock for the pharmaphorum podcast this week to give us a primer on the tumour micro-environment, what it is, how we understand it, and what it means for the future of cancer care. Lees meer